one would think that would matter .. it doesn't ..
Post# of 72440
thx to you and boo .. i have a few more comps to show .. i find it beyond ironic that an overlapping crew to both IPIX and PTOI (NNVC) has a volume issue there as well .. go figure .. in case it doesn't convey .. that would be sarcasm
directed to the embeds .. i also liked the nice touch (also sarcasm) of noting new time frames .. weeks out from today .. duly noted for what that *CONveys*
loud and clear
again for those non embeds .. who can see the forest thru the trees ..
it's *volume* .. ironically the other stock that reveals *probs* re: *volume* .. is NNVC whose *embedded crew* is easily ascertained with a minimum of *reading* .. my only awareness of NNVC is that the crew who worked cycles
of money *there* is the same that worked PTOI .. way back when
courtesy of examples' noted via this very venue ..
AVXL Last Trade 2.26
note all volume avgs are within a tight % range (i refer to this as algo *trading*)
Volume 333,479
Volume (10 day Average) 362,735
Volume (90 day Average) 327,510
Shares Outstanding 44,574,000
AXON Last Trade 1.12
Volume 505,728
Volume (10 day Average) 502,010
Volume (90 day Average) 1,321,164
Shares Outstanding 107,788,000
CRBP Last Trade 6.75
Volume 304,662
Volume (10 day Average) 481,441
Volume (90 day Average) 849,891
Shares Outstanding 57,140,000
IPIX Last Trade 0.42
Volume 508,901
Volume (10 day Average) 209,372
Volume (90 day Average) 230,502
Shares Outstanding 145,689,000
NNVC Last Trade 0.78
Volume 54,096
Volume (10 day Average) 97,160
Volume (90 day Average) 145,371
Shares Outstanding 63,373,000
OBMP Last Trade 0.0144
Volume 372,244
Volume (10 day Average) 2,437,938
Volume (90 day Average) 1,640,662
Shares Outstanding 152,670,000
4kids
Quote:
3 different drugs, multiple successful clinical trials for at least 5 different applications of the drugs.
Market cap: 63 million.
Anyone who thinks that this stock is fairly priced is not paying attention.
NNVC market cap: 50 million. No clinical trials and no prospects for any.
AVXL market cap 101 million. One very small clinical trial for an Alzheimer's drug. Alz drugs notoriously don't work.
AXON market cap 121 million. Gigantic failure in clinical trial.